Literature DB >> 25571929

Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma.

Heyun Zhang1, Wenbin Li1, Pinbo Huang1, Lehang Lin2, Hua Ye1, Dechen Lin3, H Phillip Koeffler3, Jie Wang1, Dong Yin2.   

Abstract

Studies have reported that the CCN family of proteins plays an important role in stimulating tumorigenesis. However, the relationship between the CCN protein family members and the features of hepatocellular carcinoma (HCC) remains unclear. The objective of this study was to determine the relationship between the expression levels of CCN protein family members and the features of HCC. Expression levels of the CCN family of proteins in 80-paired primary HCC samples and 11 normal liver samples were determined by a quantitative real-time PCR assay. Enhanced expression of nephroblastoma overexpressed protein (NOV) and decreased expression of Wnt-induced secreted protein 1 (WISP1), cysteine-rich protein 61 (CYR61) and connective tissue growth factor (CTGF) were found in HCC samples when compared to levels in matched non-cancerous tissues. No significant difference in WISP2 was found between matched-pair samples; only a few samples showed WISP3 expression. Furthermore, the expression levels of NOV, WISP1 and CYR61 were closely correlated with certain clinical features, including venous invasion, cellular differentiation, pTNM stage, disease-free survival and overall survival. Our results suggest that HCC progression may be enhanced by NOV and suppressed by WISP1 and CYR61. Our statistical analysis suggests that these proteins may be valuable in determining the prognosis of this deadly disease and directs attention to modulating the levels of these proteins as a potential mode of therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25571929     DOI: 10.3892/or.2015.3709

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  CCN family of proteins: critical modulators of the tumor cell microenvironment.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

2.  Talin-1 interaction network promotes hepatocellular carcinoma progression.

Authors:  Peng Chen; Xiaohu Zheng; Yonggang Zhou; Yechuan Xu; Lixin Zhu; Yeben Qian
Journal:  Oncotarget       Date:  2017-02-21

3.  Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development.

Authors:  Chih-Tien Chen; Hsiang-Lin Lee; Hui-Ling Chiou; Chia-Hsuan Chou; Po-Hui Wang; Shun-Fa Yang; Ying-Erh Chou
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

4.  CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.

Authors:  Qingan Jia; Tongchun Xue; Qiangbo Zhang; Wei Cheng; Chun Zhang; Jingwei Ma; Yang Bu; Songning Yu; Qingguang Liu
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

Review 5.  The role of CCN4/WISP-1 in the cancerous phenotype.

Authors:  Mary P Nivison; Kathryn E Meier
Journal:  Cancer Manag Res       Date:  2018-08-27       Impact factor: 3.989

Review 6.  The emerging role of WISP proteins in tumorigenesis and cancer therapy.

Authors:  Yi Liu; Yizuo Song; Miaomiao Ye; Xiaoli Hu; Z Peter Wang; Xueqiong Zhu
Journal:  J Transl Med       Date:  2019-01-16       Impact factor: 5.531

7.  Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.

Authors:  Xia Liao; Yang Bu; Fan Chang; Fengan Jia; Ge Song; Xuelian Xiao; Mei Zhang; Pengbo Ning; Qingan Jia
Journal:  BMC Cancer       Date:  2019-12-05       Impact factor: 4.430

8.  Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironment.

Authors:  Qingan Jia; Yaoyao Zhang; Binghui Xu; Xia Liao; Yang Bu; Zihan Xu; Xianglong Duan; Qiangbo Zhang
Journal:  Aging (Albany NY)       Date:  2021-09-08       Impact factor: 5.682

Review 9.  CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?

Authors:  Qingan Jia; Qiongzhu Dong; Lunxiu Qin
Journal:  Oncotarget       Date:  2016-01-12

10.  Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.

Authors:  Qunfeng Wu; Marda Jorgensen; Joanna Song; Junmei Zhou; Chen Liu; Liya Pi
Journal:  Gastroenterol Res Pract       Date:  2016-10-18       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.